Accelerating Cancer Drug Development -From target to patients, BioNow will be hosting this event at Alderley Park on the 27th of February 2018.

Focusing upon the strengths in the discovery, development and manufacture of cancer medicines in the North of England through to commercialisation (patients), this event will highlight industry, academic and clinical strengths whilst showcasing key activities, infrastructure and the joined up translational environment which exists in the North.

Dr Richard Knight will be presenting “Preclinical Safety Evaluation: Lost in Translation?”

Find out more here: Accelerating Cancer Drug Development – From target to patients